Search
Benznidazole
go.drugbank.com/drugs/DB11989ApprovedInvestigationalBenznidazole was granted accelerated approval for the treatment of Chagas disease in children 2-12 years of age by the FDA on August 29, 2017.
Tafamidis
go.drugbank.com/drugs/DB11644ApprovedInvestigational[A189717] Tafamidis was granted an EMA market authorisation on 16 November 2011[L6247] and FDA approval on 3 May 2019.[L11280]
Fedratinib
go.drugbank.com/drugs/DB12500ApprovedInvestigational[A183188] Fedratinib was granted FDA approval on August 16, 2019.[L8090]
Nivolumab
go.drugbank.com/drugs/DB09035ApprovedInvestigational[L12129] Nivolumab was granted FDA approval on 22 December 2014.[L12129] It is also available in combination with [relatlimab] under the brand name Opdualag.[L41265,L49996,L50001]
Dextromethorphan
go.drugbank.com/drugs/DB00514ApprovedInvestigational[A215412] Dextromethorphan was granted FDA approval before 3 December 1957.[A215412,L14997]
Mixtures: Maux De Gorge Et De LA Toux Extra-fortRoflumilast
go.drugbank.com/drugs/DB01656ApprovedInvestigationalThe cream formulation was first approved by the FDA in July 2022 [L42580] and by Health Canada in April 2023. … [L46546] It was first approved by the EMA in July 2010, and by the FDA in January 2018.[L37564] Roflumilast topical cream is indicated to treat plaque psoriasis.
Tick-borne encephalitis vaccine (whole virus, inactivated)
go.drugbank.com/drugs/DB16611ApprovedInvestigational[L36120] TICOVAC was granted FDA approval on August 13, 2021.[L36050]
Urokinase
go.drugbank.com/drugs/DB00013ApprovedInvestigationalWithdrawn[A191943] Urokinase was granted FDA approval on 16 January 1978.[L12138]